Sun Pharmaceutical Industries
SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth
1d
0.5%
1w
1.1%
1m
3.5%
3m
2.9%
6m
1.4%
1y
14.5%
5y
34.5%
10y
7.3%
all
17.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,713 0.5%
1,684
1,899
Company Overview

Sales
51,602 Cr
Growth: 8.8%
Profit after Tax
11,434 Cr
Growth: 3.4%
Large Cap
4,11,102 Cr
P/E: 35.9x
Industry P/E: 29.4x
Fundamentals

Sales (Cr) ₹ 51,602
Growth 8.8%
EBITDA 28.0%
P/S 8.0x
Dividend 0.9%
P/E 35.9x
Book Value ₹ 302
PEG Ratio 4.1x
ROE 16.8%
P/B 5.7x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
7.37 %
Icici Prudential Value Discovery Fund And Various Fund Accounts
3.68 %
Sbi-Etf Nifty 50 And Various Fund Accounts
1.94 %
Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts
1.37 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts
1.24 %
Promoters
Shanghvi Finance Private Limited
40.3 %
Dilip.S.Shanghvi
9.6 %
Aditya Medisales Limited
1.67 %
Raksha S.Valia
1.2 %
Sudhir V.Valia
0.6 %
Others
Llp
2.89 %
Lakshdeep Investments & Finance (P) Ltd.
1.18 %
Iepf
0.08 %
Increase    Decrease    No change
Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.
Investors (335)
Followers (135)